Ataru Sazawa

1.3k total citations
47 papers, 831 citations indexed

About

Ataru Sazawa is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Ataru Sazawa has authored 47 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Urology. Recurrent topics in Ataru Sazawa's work include Bladder and Urothelial Cancer Treatments (21 papers), Urinary and Genital Oncology Studies (18 papers) and Renal cell carcinoma treatment (9 papers). Ataru Sazawa is often cited by papers focused on Bladder and Urothelial Cancer Treatments (21 papers), Urinary and Genital Oncology Studies (18 papers) and Renal cell carcinoma treatment (9 papers). Ataru Sazawa collaborates with scholars based in Japan, United States and China. Ataru Sazawa's co-authors include Nobuo Shinohara, Takashige Abe, Katsuya Nonomura, Toru Harabayashi, Satoru Maruyama, Shin Suzuki, Takahiro Osawa, Tomohiko Koyanagi, Noboru Kuzumaki and Ryuji Matsumoto and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ataru Sazawa

46 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ataru Sazawa Japan 18 549 246 192 156 123 47 831
Jeff M. Michalski United States 8 805 1.5× 217 0.9× 287 1.5× 238 1.5× 62 0.5× 20 937
Takafumi Yanagisawa Japan 16 448 0.8× 557 2.3× 122 0.6× 247 1.6× 145 1.2× 152 951
Eric C. Bélanger Canada 18 277 0.5× 400 1.6× 45 0.2× 110 0.7× 196 1.6× 60 779
Kristin M. Sanderson United States 11 416 0.8× 178 0.7× 232 1.2× 290 1.9× 96 0.8× 14 857
Ricardo Sánchez‐Ortiz United States 18 506 0.9× 571 2.3× 250 1.3× 234 1.5× 269 2.2× 34 1.0k
Bartosz Małkiewicz Poland 12 221 0.4× 162 0.7× 76 0.4× 109 0.7× 69 0.6× 89 491
Beth G. Scherer United States 9 491 0.9× 597 2.4× 213 1.1× 119 0.8× 101 0.8× 11 1.0k
A. De La Taille France 13 142 0.3× 533 2.2× 114 0.6× 95 0.6× 222 1.8× 56 724
Keijiro Kiyoshima Japan 14 290 0.5× 467 1.9× 75 0.4× 151 1.0× 197 1.6× 41 850
K. Clint Cary United States 14 448 0.8× 333 1.4× 100 0.5× 113 0.7× 123 1.0× 28 741

Countries citing papers authored by Ataru Sazawa

Since Specialization
Citations

This map shows the geographic impact of Ataru Sazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ataru Sazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ataru Sazawa more than expected).

Fields of papers citing papers by Ataru Sazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ataru Sazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ataru Sazawa. The network helps show where Ataru Sazawa may publish in the future.

Co-authorship network of co-authors of Ataru Sazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ataru Sazawa. A scholar is included among the top collaborators of Ataru Sazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ataru Sazawa. Ataru Sazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osawa, Takahiro, et al.. (2018). Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy. PLoS ONE. 13(5). e0197252–e0197252. 5 indexed citations
2.
Matsumoto, Ryuji, Takashige Abe, Hiroshi Kikuchi, et al.. (2018). Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan. Japanese Journal of Clinical Oncology. 48(8). 771–776. 15 indexed citations
3.
Abe, Takashige, Hiroshi Kikuchi, Keita Minami, et al.. (2016). Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan. Urologic Oncology Seminars and Original Investigations. 35(2). 38.e1–38.e8. 19 indexed citations
4.
Abe, Takashige, Nobuo Shinohara, Sachiyo Murai, et al.. (2015). Diagnostic outcome of ureteroscopy in urothelial carcinoma of the upper urinary tract: Incidence of later cancer detection and its risk factors after the first examination. BMC Urology. 15(1). 92–92. 4 indexed citations
5.
Abe, Takashige, Ryuji Matsumoto, Takahiro Osawa, et al.. (2014). Outcome of Regional Lymphadenectomy in Accordance with Primary Tumor Location on Laparoscopic Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract: A Prospective Study. Journal of Endourology. 29(3). 304–309. 16 indexed citations
6.
Abe, Takashige, Ataru Sazawa, Toru Harabayashi, et al.. (2012). Renal Hypothermia with Ice Slush in Laparoscopic Partial Nephrectomy: The Outcome of Renal Function. Journal of Endourology. 26(11). 1483–1488. 18 indexed citations
7.
Shimizu, Shinichi, Yasuhiro Osaka, Nobuo Shinohara, et al.. (2011). Use of Implanted Markers and Interportal Adjustment With Real-Time Tracking Radiotherapy System to Reduce Intrafraction Prostate Motion. International Journal of Radiation Oncology*Biology*Physics. 81(4). e393–e399. 29 indexed citations
8.
Abe, Takashige, Nobuo Shinohara, Ataru Sazawa, et al.. (2011). Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: A retrospective study. International Journal of Urology. 19(2). 110–116. 17 indexed citations
9.
Abe, Takashige, Nobuo Shinohara, Ataru Sazawa, et al.. (2010). Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: Multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. European Journal of Surgical Oncology. 36(11). 1085–1091. 42 indexed citations
10.
Tatsugami, Katsunori, Kentaro Kuroiwa, Toshiyuki Kamoto, et al.. (2010). Evaluation of Narrow-Band Imaging as a Complementary Method for the Detection of Bladder Cancer. Journal of Endourology. 24(11). 1807–1811. 64 indexed citations
11.
Sazawa, Ataru, Nobuo Shinohara, Toru Harabayashi, et al.. (2009). Alternative approach in the treatment of adrenal metastasis with a real‐time tracking radiotherapy in patients with hormone refractory prostate cancer. International Journal of Urology. 16(4). 410–412. 8 indexed citations
12.
Harabayashi, Toru, et al.. (2009). A CASE OF PRIMARY LEIOMYOSARCOMA OF THE SEMINAL VESICLE. The Japanese Journal of Urology. 100(7). 703–706. 2 indexed citations
13.
Osawa, Takahiro, Takashige Abe, Nobuo Shinohara, et al.. (2008). Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: A multi‐institutional study. International Journal of Urology. 16(3). 274–278. 22 indexed citations
14.
Abe, Takashige, Nobuo Shinohara, Toru Harabayashi, et al.. (2007). Postoperative Inguinal Hernia After Radical Prostatectomy for Prostate Cancer. Urology. 69(2). 326–329. 72 indexed citations
15.
Abe, Takashige, Nobuo Shinohara, Toru Harabayashi, et al.. (2007). Impact of Multimodal Treatment on Survival in Patients with Metastatic Urothelial Cancer. European Urology. 52(4). 1106–1114. 51 indexed citations
16.
Toyoda, Yutaka, Nobuo Shinohara, Toru Harabayashi, et al.. (2006). Survival and Prognostic Classification of Patients with Metastatic Renal Cell Carcinoma of Bone. European Urology. 52(1). 163–169. 44 indexed citations
17.
Watanabe, Takafumi, Nobuo Shinohara, Ataru Sazawa, et al.. (2001). Adenovirus-mediated gene therapy for bladder cancer in an orthotopic model using a dominant negative H-ras mutant. International Journal of Cancer. 92(5). 712–717. 14 indexed citations
18.
Watanabe, Takafumi, Nobuo Shinohara, Kimihiko Moriya, et al.. (2000). Significance of the Grb2 and Son of Sevenless (Sos) Proteins in Human Bladder Cancer Cell Lines. IUBMB Life. 49(4). 317–320. 34 indexed citations
19.
Tanaka, Motoyoshi, Ataru Sazawa, Nobuo Shinohara, et al.. (1999). Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice. Cancer Gene Therapy. 6(5). 482–487. 17 indexed citations
20.
Senmaru, Naoto, Toshiaki Shichinohe, Masaki Miyamoto, et al.. (1998). Suppression of Erk activation andin vivo growth in esophageal cancer cells by the dominant negativeRas mutant, N116Y. International Journal of Cancer. 78(3). 366–371. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026